NASDAQ Global Select • Healthcare • Biotechnology • US • USD
AVROBIO, Inc. (AVRO) has a consensus analyst rating of Hold, based on 10 analysts covering the stock. Of those, 4 recommend buying, 6 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
